Cardica, Inc. (NASDAQ:CRDC)
The Company designs, manufactures and markets proprietary automated anastomotic systems used by surgeons to perform coronary artery bypass surgery.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
OklaBoston
(< 20)
Submitted: 3/24/2013 9:11:35 PM :
Start Price:
$1.34
CRDC Score:
-9.40
A director bought over a million shares on the open market 4 days ago.
Recs
maphere
(< 20)
Submitted: 3/7/2012 4:22:47 PM :
Start Price:
$1.93
CRDC Score:
-55.43
New stapler design superior to existing surgical staplers, likely to complete clinical trial 4th Quarter. Expect buyout by EOY.
Recs
Cressida
(41.14)
Submitted: 1/23/2011 2:44:27 PM :
Start Price:
$5.15
CRDC Score:
-105.46
Surgical needs increasing in this arena (see World Stats Review).
Cardica is now rev-ing up it's contract with ISRG, which may result in buyout. It is down and costing plenty to assure delivery of product to ISRG. Need is increasing, eg, demand will increase.
Even small town hospitals (Chambersburg, PA) now do robotic surgery....and advertise that !!!!
Recs
makerta
(80.14)
Submitted: 9/10/2008 1:28:10 PM :
Start Price:
$9.88
CRDC Score:
-126.49
This is a re-up. PAS-Port approval starts a new phase of growth for this company.
Recs
MagicTX
(39.46)
Submitted: 9/9/2008 6:00:40 PM :
Start Price:
$10.20
CRDC Score:
-126.71
FDA approval will send this stock upward.
Recs
davidr825
(< 20)
Submitted: 6/13/2008 7:58:39 PM :
Start Price:
$9.17
CRDC Score:
-113.23
Robotic surgery will be the wave of the future
Recs
GamblerRoy22
(< 20)
Submitted: 6/12/2008 6:29:38 PM :
Start Price:
$9.86
CRDC Score:
-115.91
with its new development in heart surgery this company should be able to erase its debt with little to no effort.
Recs
amytobin
(< 20)
Submitted: 6/10/2008 5:23:37 PM :
Start Price:
$9.71
CRDC Score:
-113.87
Demand for medical supplies always needed
Recs
rdevine1955
(35.58)
Submitted: 6/10/2008 2:31:24 PM :
Start Price:
$9.15
CRDC Score:
-113.01
promotional merchandise advertises cardica
to Medical Professionals who make the decisions.
Trend analysis says this is going up
Recs
TMFBreakerJava
(99.35)
Submitted: 5/10/2008 6:22:27 AM :
Start Price:
$7.09
CRDC Score:
-106.45
This company has a device that facilitates minimally invasive coronary bypass surgery in conjunction with the Da Vinci robotic surgical system from ISRG. Coronary bypass surgery is a large market in need of a less traumatic solution than the prevailing standard of care, which involves splitting the chest, stopping the heart and weeks of painful recovery.
This company's product facilitates the minimally invasive solution provided by the da Vinci robot which allows closed chest, beating heart bypass surgery with far faster recovery and much less post surgical pain.
Perhaps ISRG will acquire them, but this is a promising investment with or without the acquisition
Recs
gator511
(< 20)
Submitted: 3/27/2008 2:07:56 PM :
Start Price:
$7.77
CRDC Score:
-113.84
New devices coming on line later this year and the company may actually start turning a profit by 1st quarter next year
Recs
betabata
(< 20)
Submitted: 3/5/2008 3:23:33 PM :
Start Price:
$7.83
CRDC Score:
-114.50
breakthrough device
Recs
gparent2008
(71.26)
Submitted: 12/14/2007 4:32:36 PM :
Start Price:
$10.90
CRDC Score:
+105.91
had a nice bounce now bak 2 reality
Recs
cysto
(86.79)
Submitted: 11/9/2007 2:06:19 PM :
Start Price:
$8.47
CRDC Score:
+104.47
CABG surgery is on the decline and largely replaced by stenting. I don't see this being a real winner in the long run unless it is bought out
Recs
Recs
sal1015
(< 20)
Submitted: 10/17/2007 9:15:45 AM :
Start Price:
$11.65
CRDC Score:
-102.02
Their non-invasive procedure has been proven effective and is sure to be accepted by the medical community. The potential for the company is considerably higher than the market cap and eventually will trade at levels that closely resemble that potential. Although I agree that the recent dilution will put some short term pressure on the stock, the company is using its current sucess as a means of raising money that is essential to their growth and allowing their angel investor an opportunity to cash out. NONE of the key players in the company is selling stock here.
Recs
tling
(60.80)
Submitted: 10/10/2007 4:51:36 PM :
Start Price:
$13.84
CRDC Score:
-102.36
The science sounds promising. I can't wait until I get my first bypass!
Recs
HeatVision
(45.32)
Submitted: 10/8/2007 11:54:40 AM :
Start Price:
$14.29
CRDC Score:
-104.16
up,up, and and away !
Recs
anylawn
(37.92)
Submitted: 10/7/2007 12:11:45 PM :
Start Price:
$12.83
CRDC Score:
-102.74
Found this stock on the new marketwatch community website.
Recs
razormd
(64.40)
Submitted: 9/13/2007 3:56:28 PM :
Start Price:
$9.38
CRDC Score:
-104.69
Reviewed the technology and found it very impressive...c-port is now cleared for use in the US and the European union...Dr. Katz, one of the surgeons who recently used the device, said:
"The Flex A system has the potential to revolutionize the field of cardiothoracic surgery, as it enhances closed-chest, robot-assisted bypass procedures. Minimally-invasive bypass surgeries produce better patient outcomes, and substantially reduce pain and trauma and provide a quicker return to normal functionality for the patient."
...now take a look at a chart of ISRG...need I say more?
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 21 : 1 2 Next »